Go Pro
→ Iran War: What Happened at 1:11 P.M. Outside D.C.? (From Banyan Hill Publishing) (Ad)tc pixel

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Compare
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
$1.80
+3.1%		$2.00
$0.96
▼
$3.80
$134.34M1.551.12 million shs160,450 shs
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
$0.72
-4.7%		$0.82
$0.65
▼
$2.24
$4.63M2.723.06 million shs30,000 shs
OneMedNet Corporation stock logo
ONMD
OneMedNet
$0.77
-0.4%		$0.66
$0.49
▼
$4.22
$43.97M1.142.18 million shs59,720 shs
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$8.94
+1.8%		$6.04
$4.54
▼
$22.25
$166.87M1.08424,639 shs49,372 shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
-2.23%-24.24%-23.58%+47.06%-45.65%
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
+4.03%+4.91%-21.24%-18.89%-62.29%
OneMedNet Corporation stock logo
ONMD
OneMedNet
+5.20%+19.02%+6.94%-7.64%+61.90%
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
+24.72%+30.27%+34.46%+68.52%-49.34%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
$1.80
+3.1%		$2.00
$0.96
▼
$3.80
$134.34M1.551.12 million shs160,450 shs
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
$0.72
-4.7%		$0.82
$0.65
▼
$2.24
$4.63M2.723.06 million shs30,000 shs
OneMedNet Corporation stock logo
ONMD
OneMedNet
$0.77
-0.4%		$0.66
$0.49
▼
$4.22
$43.97M1.142.18 million shs59,720 shs
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$8.94
+1.8%		$6.04
$4.54
▼
$22.25
$166.87M1.08424,639 shs49,372 shs
10 Stocks Powering The Next AI Boom Cover
10 Stocks Powering The Next AI Boom

The AI boom is creating opportunities across semiconductors, cloud computing, enterprise software, infrastructure, cybersecurity, and automation.

Inside this report, you’ll find 10 companies positioned to benefit as artificial intelligence moves from hype to real-world deployment and becomes a core growth driver for corporate America.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
-2.23%-24.24%-23.58%+47.06%-45.65%
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
+4.03%+4.91%-21.24%-18.89%-62.29%
OneMedNet Corporation stock logo
ONMD
OneMedNet
+5.20%+19.02%+6.94%-7.64%+61.90%
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
+24.72%+30.27%+34.46%+68.52%-49.34%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
2.23
Hold$2.9367.53% Upside
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
1.50
ReduceN/AN/A
OneMedNet Corporation stock logo
ONMD
OneMedNet
1.00
SellN/AN/A
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
2.56
Moderate Buy$13.1449.69% Upside

Current Analyst Ratings Breakdown

Latest ONMD, LUCY, HCAT, and OPRX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
8/13/2026
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Stifel Nicolaus logo
Stifel Nicolaus
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Set Price Target$12.00
8/13/2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetEqual Weight$1.75 ➝ $1.50
8/11/2026
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (D)
8/11/2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Lower Price TargetNeutral$2.50 ➝ $2.00
7/28/2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
UpgradeSell (E+) ➝ Sell (D-)
7/23/2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Citigroup Inc. logo
Citigroup
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingNeutral
7/21/2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Canaccord Genuity Group Inc. logo
Canaccord Genuity Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetBuy$2.00 ➝ $3.00
7/17/2026
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/26/2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Wells Fargo & Company logo
Wells Fargo & Company
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Boost Price TargetEqual Weight$1.00 ➝ $1.75
6/24/2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
Weiss Ratings logo
Weiss Ratings
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
Reiterated RatingSell (E+)
6/3/2026
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
Maxim Group logo
Maxim Group
Subscribe to MarketBeat All Access for the firm's recommendation accuracy rating
DowngradeBuy ➝ Hold
(Data available from 8/14/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
$311.14M0.42$2.08 per share0.84$3.47 per share0.50
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
$2.66M1.81N/AN/A$1.69 per share0.45
OneMedNet Corporation stock logo
ONMD
OneMedNet
$1.36M32.54N/AN/A($0.06) per share-12.95
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$109.43M1.51$1.23 per share7.15$6.88 per share1.28
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
-$177.97M-$3.68N/AN/AN/A-90.61%-1.57%-0.75%N/A
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
-$7.59M-$1.69N/AN/AN/A-272.42%-83.37%-76.02%N/A
OneMedNet Corporation stock logo
ONMD
OneMedNet
-$2.80M-$0.05N/AN/AN/A-254.13%N/A-383.90%N/A
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$5.13M$0.3538.1814.63N/A4.66%9.52%7.03%N/A

Latest ONMD, LUCY, HCAT, and OPRX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/12/2026Q2 2026
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
$0.1111$0.16+$0.0489-$0.04$20.20 million$20.50 million
8/6/2026Q2 2026
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
$0.0299$0.04+$0.0101-$0.55$69.09 million$70.49 million
5/15/2026Q1 2026
OneMedNet Corporation stock logo
ONMD
OneMedNet
N/A-$0.04N/A-$0.04N/A$0.10 million
5/14/2026Q1 2026
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
-$0.47-$0.37+$0.10-$0.37$0.70 million$0.77 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
N/AN/AN/AN/AN/A
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
N/AN/AN/AN/AN/A
OneMedNet Corporation stock logo
ONMD
OneMedNet
N/AN/AN/AN/AN/A
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
1.10
1.69
1.69
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
N/A
8.02
6.09
OneMedNet Corporation stock logo
ONMD
OneMedNet
N/A
0.27
0.27
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
0.16
5.37
5.37

Institutional Ownership

CompanyInstitutional Ownership
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
85.00%
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
0.96%
OneMedNet Corporation stock logo
ONMD
OneMedNet
0.95%
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
76.47%

Insider Ownership

CompanyInsider Ownership
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
19.40%
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
1.66%
OneMedNet Corporation stock logo
ONMD
OneMedNet
46.20%
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
7.50%
CompanyEmployeesShares OutstandingFree FloatOptionable
Health Catalyst, Inc. stock logo
HCAT
Health Catalyst
1,20075.26 million60.66 millionOptionable
Innovative Eyewear, Inc. stock logo
LUCY
Innovative Eyewear
96.40 million6.30 millionNot Optionable
OneMedNet Corporation stock logo
ONMD
OneMedNet
256.95 million30.64 millionN/A
OptimizeRx Corp. stock logo
OPRX
OptimizeRx
10018.76 million17.36 millionOptionable

Recent News About These Companies

OptimizeRx (NASDAQ:OPRX) Stock Price Expected to Rise, Citizens Jmp Analyst Says
 |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/optimizerx-nasdaqoprx-stock-price-expected-to-rise-citizens-jmp-analyst-says-2026-08-14/
Renaissance Technologies LLC Has $1.36 Million Stock Position in OptimizeRx Corp. $OPRX
August 14 at 4:31 AM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-renaissance-technologies-llc-has-136-million-stock-position-in-optimizerx-corp-oprx-2026-08-14/
OptimizeRx Corp (OPRX) (Q2 2026) Earnings Call Highlights: Navigating Revenue Headwinds with ...
August 13 at 8:07 AM  |  uk.finance.yahoo.comhttps://uk.finance.yahoo.com/news/optimizerx-corp-oprx-q2-2026-050346456.html
OptimizeRx Announces Finance Leadership Appointments to Support the Next Phase of Growth
August 13 at 8:07 AM  |  finance.yahoo.comhttps://finance.yahoo.com/healthcare/articles/optimizerx-announces-finance-leadership-appointments-200500530.html
OptimizeRx reiterates $95M-$100M 2026 revenue outlook amid CFO transition
August 13 at 8:07 AM  |  seekingalpha.comhttps://seekingalpha.com/news/4632012-optimizerx-reiterates-95m-100m-2026-revenue-outlook-amid-cfo-transition
OptimizeRx Q2 Earnings Call Highlights
August 12 at 9:03 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/optimizerx-q2-earnings-call-highlights-2026-08-12/
OptimizeRx Corporation (OPRX) Q2 2026 Earnings Call Transcript
August 12 at 8:00 PM  |  seekingalpha.comhttps://seekingalpha.com/article/4935660-optimizerx-corporation-oprx-q2-2026-earnings-call-transcript
OptimizeRx Corp. (OPRX) Q2 Earnings and Revenues Top Estimates
August 12 at 6:41 PM  |  zacks.comhttps://www.zacks.com/stock/news/2973878/optimizerx-corp-oprx-q2-earnings-and-revenues-top-estimates?cid=cs-stocknewsapi-ft-fundamental_analysis|yseop_template_4-2973878
OptimizeRx (NASDAQ:OPRX) Announces Earnings Results, Beats Estimates By $0.05 EPS
August 12 at 5:10 PM  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/optimizerx-nasdaqoprx-announces-earnings-results-beats-estimates-by-005-eps-2026-08-12/
OptimizeRx Reaffirms 2026 Outlook Amid Revenue Decline
August 12 at 4:31 PM  |  tipranks.comhttps://www.tipranks.com/news/company-announcements/optimizerx-reaffirms-2026-outlook-amid-revenue-decline?utm_source=marketbeat.com&utm_medium=referral
OptimizeRx Reports Second Quarter 2026 Financial Results and Updates Fiscal Year 2026 Guidance
August 12 at 4:01 PM  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/08/12/3344034/0/en/optimizerx-reports-second-quarter-2026-financial-results-and-updates-fiscal-year-2026-guidance.html
OptimizeRx (OPRX) Projected to Announce Quarterly Earnings on Wednesday
August 11 at 1:26 AM  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30953131
Segall Bryant & Hamill LLC Invests $1.19 Million in OptimizeRx Corp. $OPRX
August 6, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/filing-segall-bryant-hamill-llc-invests-119-million-in-optimizerx-corp-oprx-2026-08-06/
Brokerages Set OptimizeRx Corp. (NASDAQ:OPRX) Price Target at $13.43
August 6, 2026  |  americanbankingnews.comhttps://www.americanbankingnews.com/?p=30944795
OptimizeRx Corp. (NASDAQ:OPRX) Given Consensus Recommendation of "Moderate Buy" by Brokerages
August 1, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/optimizerx-corp-nasdaqoprx-given-consensus-recommendation-of-moderate-buy-by-brokerages-2026-08-01/
OptimizeRx (OPRX) Projected to Announce Quarterly Earnings on Thursday
July 30, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/optimizerx-oprx-projected-to-announce-quarterly-earnings-on-thursday-2026-07-30/
OptimizeRx Sets Second Quarter 2026 Conference Call for August 12, 2026, at 4:30 p.m. ET
July 29, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/29/3335125/0/en/optimizerx-sets-second-quarter-2026-conference-call-for-august-12-2026-at-4-30-p-m-et.html
OptimizeRx Appoints Veteran Point of Care Marketing Leader Sarah Bast as Chief Marketing Officer
July 23, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/07/23/3332033/0/en/optimizerx-appoints-veteran-point-of-care-marketing-leader-sarah-bast-as-chief-marketing-officer.html
OptimizeRx (NASDAQ:OPRX) Cut to "Buy" at Wall Street Zen
July 20, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/optimizerx-nasdaqoprx-cut-to-buy-at-wall-street-zen-2026-07-20/
OptimizeRx Corp. (NASDAQ:OPRX) Sees Significant Decline in Short Interest
July 16, 2026  |  marketbeat.comhttps://www.marketbeat.com/instant-alerts/optimizerx-corp-nasdaqoprx-sees-significant-decline-in-short-interest-2026-07-16/
OptimizeRx Launches CopayCue™, a Next-Generation Copay Activation Solution Powered by Real-Time Prescribing Intent
June 30, 2026  |  globenewswire.comhttps://www.globenewswire.com/news-release/2026/06/30/3319553/0/en/optimizerx-launches-copaycue-a-next-generation-copay-activation-solution-powered-by-real-time-prescribing-intent.html

New MarketBeat Followers Over Time

Media Sentiment Over Time

Health Catalyst stock logo

Health Catalyst NASDAQ:HCAT

$1.80 +0.05 (+3.09%)
As of 10:08 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases. It offers services expertise solutions comprising data and analytics, domain expertise and education, tech-enabled managed, and implementation services; and opportunity analysis and prioritization, data governance, data modeling and analysis, quality and process improvement strategy, cost accounting, data abstraction, and population health strategies. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is headquartered in South Jordan, Utah.

Innovative Eyewear stock logo

Innovative Eyewear NASDAQ:LUCY

$0.72 -0.04 (-4.68%)
As of 10:08 AM Eastern
This is a fair market value price provided by Massive. Learn more.

Innovative Eyewear, Inc. develops and sells smart eyeglasses and sunglasses. The company's flagship product is Lucyd Lyte glasses that enable the wearer to listen to music, take and make calls, and use voice assistants to perform various smartphone tasks hands-free. It also offers Vyrb, a social media application that enables the user to receive and send posts through Lucyd Lyte smart glasses with voice. In addition, the company launches an application, Lucyd app for iOS/Android users. It sells its products through various e-commerce, and retail store and distribution channels. Innovative Eyewear, Inc. has a license agreement with Lucyd Ltd. The company was incorporated in 2019 and is headquartered in North Miami, Florida. Innovative Eyewear, Inc. is a subsidiary of Lucyd Ltd.

OneMedNet stock logo

OneMedNet NASDAQ:ONMD

$0.77 0.00 (-0.40%)
As of 10:08 AM Eastern
This is a fair market value price provided by Massive. Learn more.

OneMedNet Corporation provides clinical imaging solutions. It offers iRWD, a solution that utilizes AI to securely de-identify, search, and curate imaging data for its partner network consisting of medical and academic research institutions to generate progression in stages of medical research, discovery and diagnostics that span the field of life sciences. OneMedNet Corporation is based in Eden Prairie, Minnesota.

OptimizeRx stock logo

OptimizeRx NASDAQ:OPRX

$8.94 +0.16 (+1.77%)
As of 10:09 AM Eastern
This is a fair market value price provided by Massive. Learn more.

OptimizeRx Corporation, a digital health technology company, enables care-focused engagement between life sciences organizations, healthcare providers, and patients at critical junctures throughout the patient care journey. It offers various tech-enabled marketing solutions through its Artificial Intelligence-generated Dynamic Audience and Activation Platform, which enables customers to execute traditional marketing campaigns on its proprietary digital point-of-care network, as well as dynamic marketing campaigns that optimize audiences in real time to increase the value of treatment information for healthcare professionals and patients in response to clinical care events. The company was founded in 2006 and is based in Waltham, Massachusetts.

Stock Comparison Ideas (A-K)

Stock Comparison Ideas (L-Z)

Stock Lists
Low Priced Stocks
Stocks By Exchange
Latest Stock Ideas